Fremont, CA, United States of America

Daniel Tuse


Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 155(Granted Patents)


Location History:

  • Fremont, CA (US) (1987 - 1995)
  • Menlo Park, CA (US) (2000 - 2002)

Company Filing History:


Years Active: 1987-2002

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Tuse

Introduction

Daniel Tuse is a notable inventor based in Fremont, CA (US), recognized for his significant contributions to the field of medical technology. With a total of 8 patents, Tuse has focused on developing methods that address critical health issues, particularly those related to inflammatory diseases and angiogenesis.

Latest Patents

Among his latest patents, Tuse has developed a method for inhibiting inflammatory diseases. This invention specifically targets conditions such as Crohn's disease and ulcerative colitis, providing effective strategies for reducing or inhibiting granulomas. Additionally, he has created methods for inhibiting unwanted angiogenesis, which is crucial for treating diseases characterized by excessive blood vessel growth. This invention also includes techniques for delivering anti-angiogenic activity to mammals and reducing the levels of tumor necrosis factor alpha.

Career Highlights

Throughout his career, Daniel Tuse has worked with esteemed organizations, including SRI International. His work has significantly impacted the medical field, particularly in developing innovative solutions for complex health challenges.

Collaborations

Tuse has collaborated with various professionals, including Leslie A. Hokama and Irene Casey, enhancing the scope and effectiveness of his inventions.

Conclusion

Daniel Tuse's innovative work and dedication to addressing critical health issues through his patents exemplify the spirit of invention. His contributions continue to pave the way for advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…